Vestal Point Capital’s Gilead Sciences GILD Stock Holding History

Vestal Point Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-50,000	Closed	-$6.14M	–	100
2025 Q4	$6.14M	Buy	+50,000	New	+$6.08M	0.21%	58
2024 Q4	–	Sell	-200,000	Closed	-$16.8M	–	84
2024 Q3	$16.8M	Buy	+200,000	New	+$15.3M	1.27%	25

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vestal Point Capital's GILD Position: Q1 2026 in Review

Vestal Point Capital sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 50,000 shares — an estimated $6.14M sold.

Vestal Point Capital first reported a position in GILD in Q3 2024 and held it in 2 quarters. The position peaked at $16.8M in Q3 2024. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Vestal Point Capital reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
Vestal Point Capital sold 50,000 Gilead Sciences shares in Q1 2026, an estimated $6.14M.
Vestal Point Capital first reported a position in Gilead Sciences in Q3 2024 and held it in 2 quarters.
Vestal Point Capital's Gilead Sciences position peaked at $16.8M in Q3 2024.
2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Vestal Point Capital's 13F filing for Q1 2026, filed 15 May 2026.